{
  "drug_name": "paliperidone",
  "nbk_id": "NBK610690",
  "url": "https://www.ncbi.nlm.nih.gov/books/NBK610690/",
  "scraped_at": "2026-01-11T15:35:49",
  "sections": {
    "toxicity": "DMSs are most commonly treated with antipsychotics. These medications are commonly associated with extrapyramidal symptoms, including:\n\nTardive syndromes (eg, tardive dyskinesia, tardive dystonia, and tardive akathisia)\nCharacterized by involuntary movements of the limbs, trunk, and face (tongue protrusion, grimacing, excessive blinking)\nOften develop after months to years of exposure to the medication\nMore common with first-generation antipsychotics and may not improve upon reduction or discontinuation\nTreated with vesicular monoamine transporter 2 inhibitors (eg, valbenazine or deutetrabenazine), particularly tardive dyskinesia\nDrug-induced parkinsonism/antipsychotic-induced parkinsonism\nBradykinesia, tremors, muscle rigidity, akinesia\nManaged by a reduction in dose, switching medications, or anticholinergic medications (eg, benztropine)\nAkathisia\nRestlessness, purposeless movements, and urges to move\nDevelops after days to weeks of treatment\nMore common with first-generation antipsychotics than with second-generation antipsychotics\nManaged by a reduction in dose, switching medications, anticholinergic medications such as benztropine, or beta antagonists such as propranolol\nAcute dystonia\nProlonged muscle contractions, which may be life-threatening depending on the muscle affected (eg, torticollis, laryngospasm, and oculogyric crisis)\nMore common in first-generation antipsychotic\nManaged by discontinuation of medication and initiation of anticholinergic medications such as benztropine\nNeuroleptant malignant syndrome\nMuscle rigidity, elevated creatinine phosphokinase, autonomic instability, altered mental status, fever\nMortality rate of 5%\nA medical emergency warranting transfer to the intensive care unit\nManage moderate to severe conditions with dantrolene and bromocriptine; electroconvulsive therapy suggested for refractory cases\n[37]\n\nOther than extrapyramidal symptoms, antipsychotics may present with other adverse effects, including:\n\nHyperprolactinemia due to dopamine D\n2\nreceptor antagonism in the anterior pituitary\nWeight gain, insulin resistance, and hyperlipidemia\nAnticholinergic adverse effects, including urine and fecal retention\nQTc prolongation\nOrthostatic hypotension"
  }
}